A:telbivudine

2 trials

Sponsors

Eastern Hepatobiliary Surgical hospital, Center of infectious Diseases, West China Hospital of Sichuan University

Conditions

Chronic Hepatitis Bhepatitis B-related hepatocellular carcinoma

Phase 4

The efficacy of entecavir and telbivudine in HBeAg positive chronic hepatitis B patients with high viral load

Active, not recruitingChiCTR-OCC-11001776

Center of infectious Diseases, West China Hospital of Sichuan UniversityChronic Hepatitis B

Start: 2008-11-01Updated: 2017-04-18

A randomized controlled trial:Evaluating the impact of telbivudine treatment on the prognosis of HBV-related liver cancer and posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma.

Active, not recruitingChiCTR-IPR-15006587

Eastern Hepatobiliary Surgical hospitalhepatitis B-related hepatocellular carcinoma

Start: 2008-11-01Updated: 2017-04-18

Related Papers

Antiviral therapy to reduce hepatocellular carcinoma recurrence in patients with low HBV-DNA levels: A randomized controlled trial.

Journal of Clinical Oncology2019-05-20